Assessment of quality of life and psychosocial problems in children with Congenital Heart Disease

Basit Öğe Kaydı
dc.authoridYilmaz, Kamil/0000-0001-5137-0501
dc.contributor.authorOztoprak, Meral Bulbul
dc.contributor.authorBilici, Meki
dc.contributor.authorDogac, Tugba
dc.contributor.authorAkin, Alper
dc.contributor.authorTure, Mehmet
dc.contributor.authorBalik, Hasan
dc.contributor.authorYilmaz, Kamil
dc.date.accessioned2025-02-22T14:08:59Z
dc.date.available2025-02-22T14:08:59Z
dc.date.issued2024
dc.departmentDicle Üniversitesien_US
dc.description.abstractObjective: Congenital heart disease (CHD) is a condition that can significantly impact health-related quality of life due to the need for long-term follow-up and treatment. The purpose of this study was to analyse the quality of life of children diagnosed with CHD and to assess the relationship between the disease and their physical and mental well-being. Materials and Methods: The study involved 180 patients and 180 healthy controls. Both groups were divided into three age categories (5-7 years, 8-12 years, and 13-18 years), with 60 children in each age group. The researchers administered the Pediatric Quality of Life Inventory (PedsQL) to the participants, taking into account their age. Results: Comparisons between the patient and control groups showed that the patient group had significantly lower scores than the control group in terms of total quality of life scale score, physical health score, and psychosocial health score of the Pediatric Quality of Life Inventory (p < 0.001, p < 0.001, and p < 0.001). Quality of life was also compared between patients receiving and not receiving medication treatment. Patients receiving medication treatment had lower scores for total quality of life score, physical health score, and psychosocial health score of the Pediatric Quality of Life Inventory compared to the control group (p < 0.001, p = 0.005, and p < 0.001). Conclusion: Children with CHD experience a negative impact on their quality of life. Given the extended life expectancy resulting from new treatment options, it is important to monitor these children both physically and psychosocially and to implement activities aimed at improving their quality of life.en_US
dc.identifier.doi10.1017/S1047951124026155
dc.identifier.endpage2322en_US
dc.identifier.issn1047-9511
dc.identifier.issn1467-1107
dc.identifier.issue11en_US
dc.identifier.pmid39865571en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage2316en_US
dc.identifier.urihttps://doi.org/10.1017/S1047951124026155
dc.identifier.urihttps://hdl.handle.net/11468/29741
dc.identifier.volume34en_US
dc.identifier.wosWOS:001407191000009
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherCambridge Univ Pressen_US
dc.relation.ispartofCardiology in the Youngen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmzKA_WOS_20250222
dc.subjectCongenital heart diseaseen_US
dc.subjectquality of lifeen_US
dc.subjectPediatric Quality of Life Inventoryen_US
dc.titleAssessment of quality of life and psychosocial problems in children with Congenital Heart Diseaseen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu